A Prospective, Randomized, Masked, Placebo‐Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite

BACKGROUND: Reduced appetite is a common clinical sign in dogs. This study evaluated the effectiveness and safety of capromorelin oral solution, (ENTYCE(®), Aratana Therapeutics, Leawood, KS) a new drug that is a ghrelin receptor agonist, for stimulation of appetite in dogs with reduced appetite. HY...

Descripción completa

Detalles Bibliográficos
Autores principales: Zollers, B., Wofford, J.A., Heinen, E., Huebner, M., Rhodes, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115193/
https://www.ncbi.nlm.nih.gov/pubmed/27859746
http://dx.doi.org/10.1111/jvim.14607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115193/
https://www.ncbi.nlm.nih.gov/pubmed/27859746
http://dx.doi.org/10.1111/jvim.14607

Ejemplares similares